YBX1 and nasopharyngeal carcinoma: Elevated YBX1 expression is linked to poorer prognosis in nasopharyngeal carcinoma (NPC), suggesting its potential as a prognostic biomarker for NPC patients, aiding clinicians in treatment evaluation and strategy adjustment (134).